CSI Market
Sign In | Register

Acura Pharmaceuticals inc (ACUR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ACUR Annual Cash Flow →
Looking at cash flow data from Acura Pharmaceuticals inc through Dec 31 2020 provides insight into Dec 31 2021's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2021)
12 Months 		(Sep 30 2021) (Jun 30 2021) (Mar 31 2021) (Dec 31 2020)
Operating Activities
Income-0.88
Depreciation & amortization0.05
Amortization of Other Assets0.03
Increase (Decrease) in Deferred Revenue0.00
Impairment of Intangible Assets, Finite-lived0.05
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation0.06
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Provision To Reduce Inventory To Net Realizable Value-
Marketable Securities Gain Loss-
Increase Decrease In Collaboration Revenue Receivable0.12
Provision For Sales Returns-
Amortization Of Bond Premium In Marketable Securities-
Capitalized Debt Discount-
Increase Decrease In Interest Payable To Related Party0.20
Increase Decrease In Royalty Receivable-0.04
Finance Lease Right Of Use Asset Amortization0.01
Income taxes0.00
Increase (Decrease) in Accrued Investment Income Receivable0.00
Increase (Decrease) in Income Taxes Receivable0.00
Increase (Decrease) in Accounts Payable0.16
Increase (Decrease) in Accrued Liabilities-0.39
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.01
Other Working Capital0.05
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.19
Discontinued operations0.00
Net Cash flow from Operating Activities-0.74
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Product Warranty Accrual Additions From Business Acquisition-
Proceeds From Sale Of Inventory-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.27
Other borrowing transactions0.00
Long-term debt - borrowings0.15
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.42
Proceeds From Market Offering Of Shares-
Proceeds From Issuance Of Common Stock Value Under Market Offerings-
Payments Of Transaction Costs From Registered Direct Offering-
Principal Transactions Revenue-
Proceeds From Distribution Of Restricted Stock Units0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.41
Gain On Paycheck Protection Program Loan Forgiveness Cares Act-0.27
Finance Lease Principal Payments-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.39
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.74
Total Cash Flow-0.35
4 historic quarters locked

Sign in to unlock the full Acura Pharmaceuticals inc cash flow history.

Sign In Create Free Account

About Acura Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001410578-23-001462

Figures are derived from filed reports and may be restated. Historical data is subject to revision.